True Wealth Design’s Avita Medical RCEL Stock Holding History

True Wealth Design’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-147	Closed	-$608	–	2745
2026 Q2	$608	Buy	147 +138	+1,533%	+$595	﹤0.01%	2133
2026 Q1	$34	Buy	9 +7	+350%	+$29	﹤0.01%	2595
2025 Q4	$7	Sell	2 -2	-50%	-$8	﹤0.01%	2540
2025 Q3	$21	Buy	+4	New	+$21	﹤0.01%	2657
2025 Q2	–	Sell	-109	Closed	-$888	–	2780
2025 Q1	$888	Buy	+109	New	+$1.02K	﹤0.01%	1307

Other funds holding RCEL

HCA

Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's RCEL Position: Q3 2026 in Review

True Wealth Design sold out of Avita Medical (RCEL) in Q3 2026, closing a stake of 147 shares — an estimated $608 sold.

True Wealth Design first reported a position in RCEL in Q1 2025 and held it in 5 quarters. The position peaked at $888 in Q1 2025. 4 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

True Wealth Design reported no remaining Avita Medical position as of Q3 2026 after selling out during the quarter.
True Wealth Design sold 147 Avita Medical shares in Q3 2026, an estimated $608.
True Wealth Design first reported a position in Avita Medical in Q1 2025 and held it in 5 quarters.
True Wealth Design's Avita Medical position peaked at $888 in Q1 2025.
4 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.